000 01596 a2200493 4500
005 20250518100930.0
264 0 _c20210625
008 202106s 0 0 eng d
022 _a1468-1331
024 7 _a10.1111/ene.14285
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBrannagan, T H
245 0 0 _aEarly data on long-term efficacy and safety of inotersen in patients with hereditary transthyretin amyloidosis: a 2-year update from the open-label extension of the NEURO-TTR trial.
_h[electronic resource]
260 _bEuropean journal of neurology
_c08 2020
300 _a1374-1381 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAmyloid Neuropathies, Familial
_xdrug therapy
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aOligonucleotides
650 0 4 _aPrealbumin
650 0 4 _aQuality of Life
700 1 _aWang, A K
700 1 _aCoelho, T
700 1 _aWaddington Cruz, M
700 1 _aPolydefkis, M J
700 1 _aDyck, P J
700 1 _aPlante-Bordeneuve, V
700 1 _aBerk, J L
700 1 _aBarroso, F
700 1 _aMerlini, G
700 1 _aConceição, I
700 1 _aHughes, S G
700 1 _aKwoh, J
700 1 _aJung, S W
700 1 _aGuthrie, S
700 1 _aPollock, M
700 1 _aBenson, M D
700 1 _aGertz, M
773 0 _tEuropean journal of neurology
_gvol. 27
_gno. 8
_gp. 1374-1381
856 4 0 _uhttps://doi.org/10.1111/ene.14285
_zAvailable from publisher's website
999 _c30909448
_d30909448